We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.61B
1-Year Est. Return
28.28%
This Fund
S&P 500
This Quarter
Est. Return
+9.02%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.27B
AUM Growth
+$957K
(+0.08%)
Cap. Flow
-$81.4M
Cap. Flow
% of AUM
-6.43%
Top 10 Holdings %
Top 10 Hldgs %
5.55%
Holding
1,966
New
431
Increased
565
Reduced
590
Closed
359
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$7.23M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$7.08M |
| 3 |
Pfizer
PFE
|
+$6.7M |
| 4 |
Best Buy
BBY
|
+$6.21M |
| 5 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$6.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$12.3M |
| 2 |
HP
HPQ
|
+$8.76M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$8.48M |
| 4 |
Baxter International
BAX
|
+$6.78M |
| 5 |
Marathon Petroleum
MPC
|
+$6.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 12.7% |
| 2 | Healthcare | 12.7% |
| 3 | Consumer Discretionary | 11.82% |
| 4 | Technology | 11.74% |
| 5 | Financials | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
URS
1176
DELISTED
URS CORP
URS
| $310K | 0.02% |
+5,846
| New | +$308K |
|
1177
Amazon
AMZN
$2.99T
| $309K | 0.02% |
+15,480
| New | +$278K |
|
1178
AngioDynamics
ANGO
$628M
| $309K | 0.02% |
+17,964
| New | +$276K |
|
|
FFKT
1179
DELISTED
Farmers Capital Bank Corp
FFKT
| $309K | 0.02% |
+14,200
| New | +$302K |
|
1180
Keurig Dr Pepper
KDP
$42.3B
| $308K | 0.02% |
6,319
+1,455
| +30% | +$68.5K |
|
1181
CarMax
KMX
$8.16B
| $307K | 0.02% |
6,532
-26,304
| -80% | -$1.29M |
|
|
GXP
1182
DELISTED
Great Plains Energy Incorporated
GXP
| $307K | 0.02% |
12,659
+2,076
| +20% | +$49K |
|
|
TESO
1183
DELISTED
Tesco Corp
TESO
| $307K | 0.02% |
15,520
-3,517
| -18% | -$63.4K |
|
1184
Cirrus Logic
CRUS
$6.74B
| $306K | 0.02% |
14,995
+106
| +0.7% | +$2.29K |
|
|
GWR
1185
DELISTED
Genesee & Wyoming Inc.
GWR
| $306K | 0.02% |
+3,183
| New | +$307K |
|
1186
Cigna
CI
$72.4B
| $305K | 0.02% |
3,491
-35,516
| -91% | -$2.91M |
|
1187
Integra LifeSciences
IART
$1.39B
| $305K | 0.02% |
15,662
-734
| -4% | -$13.5K |
|
1188
TriMas Corp
TRS
$1.45B
| $305K | 0.02% |
+9,599
| New | +$292K |
|
|
ARRS
1189
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $305K | 0.02% |
12,500
-24,725
| -66% | -$472K |
|
1190
First Solar
FSLR
$26.2B
| $304K | 0.02% |
5,563
-23,259
| -81% | -$1.27M |
|
|
SN
1191
DELISTED
Sanchez Energy Corporation
SN
| $304K | 0.02% |
12,416
+454
| +4% | +$12.1K |
|
|
CNVR
1192
DELISTED
CONVERSANT INC COM STK (DE)
CNVR
| $304K | 0.02% |
13,008
-6,953
| -35% | -$146K |
|
1193
Aaon
AAON
$7.83B
| $303K | 0.02% |
+21,317
| New | +$270K |
|
1194
WSFS Financial
WSFS
$4.21B
| $303K | 0.02% |
+11,721
| New | +$274K |
|
|
CCIH
1195
DELISTED
Chinacache International Holdings Ltd
CCIH
| $303K | 0.02% |
+34,000
| New | +$272K |
|
1196
VEON
VEON
$3.76B
| $302K | 0.02% |
935
-894
| -49% | -$286K |
|
1197
Hallador Energy
HNRG
$713M
| $301K | 0.02% |
37,400
+13,300
| +55% | +$98.9K |
|
1198
Melco Resorts & Entertainment
MLCO
$2.17B
| $299K | 0.02% |
+7,624
| New | +$269K |
|
1199
Madison Square Garden
MSGS
$9.51B
| $299K | 0.02% |
+7,292
| New | +$297K |
|
1200
Perdoceo Education
PRDO
$2.06B
| $299K | 0.02% |
52,535
-13,400
| -20% | -$59.4K |
|
Similar funds
ACB
SCI
SCM
BW
HH
KCM
PRA
CC
GSA Capital Partners's Q4 2013 Portfolio in Review
As of Q4 2013, GSA Capital Partners held 1,966 positions worth $1.27B, up 0.08% from $1.26B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.
GSA Capital Partners withdrew a net $81.4M in Q4 2013, closing 359 positions and reducing 590 holdings. Its most notable exit was CVS Health, an estimated $12.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, GSA Capital Partners opened a new position in Pfizer worth $6.69M.
- GSA Capital Partners's largest Q4 2013 buy was Pfizer: 230,320 shares worth $6.69M.
- GSA Capital Partners added most to CME Group in Q4 2013, an estimated $7.23M increase.
- GSA Capital Partners's biggest Q4 2013 reduction was HP, cutting an estimated $8.76M.
- GSA Capital Partners fully exited CVS Health in Q4 2013, selling an estimated $12.3M.
- GSA Capital Partners's ten largest holdings make up 5.6% of its $1.27B portfolio in Q4 2013.
- GSA Capital Partners opened 431 new positions and closed 359 in Q4 2013.
- GSA Capital Partners's portfolio value rose 0.08% quarter-over-quarter to $1.27B.
Based on GSA Capital Partners's 13F filing for Q4 2013, filed 12 Feb 2014.